AtriCure (ATRC) Chief Mktg & Strategy Officer Justin Noznesky Sells Shares

What Happened
Justin J. Noznesky, AtriCure's Chief Marketing & Strategy Officer, sold 6,182 shares of ATRC in an open-market transaction on July 29, 2026. The weighted-average sale price was $38.80 per share, for total proceeds of $239,862. This was a sale (not a purchase or option exercise), which is often a routine disposition by insiders.

Key Details

• Transaction date: 2026-07-29 (filed with the SEC on 2026-07-30; timely filing).
• Transaction type/code: Open-market sale (S).
• Shares sold: 6,182; weighted-average price: $38.80; total proceeds: $239,862.
• Reported price range (multiple trades): $38.62 to $39.28 per share (footnote states weighted average reported; full trade-level details available on request).
• Shares owned after transaction: Not reported in the filing.
• Footnote: Reporting person will provide, upon request, the number of shares and prices for each trade that made up the weighted average.

Context
Sales by executives can be routine (for diversification, tax planning, or liquidity) and do not by themselves indicate a change in company outlook. No 10b5-1 plan, grant, exercise, or gift was disclosed in this filing.